Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer

MLA

Gul Ege Aktas, et al. “Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Derived Metabolic Parameters in Surgically Resected Clinical-N0 Nonsmall Cell Lung Cancer.” Nuclear Medicine Communications, vol. 39, Nov. 2018, pp. 995–1004. EBSCOhost, https://doi.org/10.1097/mnm.0000000000000903.

APA

Gul Ege Aktas, Ali Sarikaya, Ismet Sarikaya, Necdet Sut, Yekta Altemur Karamustafaoglu, & Cenk Balta. (2018). Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer. Nuclear Medicine Communications, 39, 995–1004. https://doi.org/10.1097/mnm.0000000000000903

Chicago

Gul Ege Aktas, Ali Sarikaya, Ismet Sarikaya, Necdet Sut, Yekta Altemur Karamustafaoglu, and Cenk Balta. 2018. “Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Derived Metabolic Parameters in Surgically Resected Clinical-N0 Nonsmall Cell Lung Cancer.” Nuclear Medicine Communications 39 (November): 995–1004. doi:10.1097/mnm.0000000000000903.